OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA

被引：1
|
作者：
Elsey, L. [1 ]
Hince, K. [1 ]
Aspin, P. [1 ]
Pantin, C. T. [1 ]
Allen, D. [1 ]
Niven, R. [2 ]
Fowler, S. J. [2 ]
Tavernier, G. [2 ]
机构：
[1] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2020-BTSabstracts.246
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P101
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [1] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [2] Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab
    Bergantini, Laura
    d'Alessandro, Miriana
    Cameli, Paolo
    Bianchi, Francesco
    Sestini, Piersante
    Bargagli, Elena
    Refini, Rosa Metella
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2020, 181 (10) : 746 - 753
  • [3] Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
    Desaintjean, Charlene
    Ahmad, Kais
    Traclet, Julie
    Gerfaud-Valentin, Mathieu
    Durel, Cecile-Audrey
    Glerant, Jean-Charles
    Hot, Arnaud
    Lestelle, Francois
    Mainbourg, Sabine
    Nasser, Mouhamad
    Seve, Pascal
    Turquier, Segolene
    Devouassoux, Gilles
    Cottin, Vincent
    FRONTIERS IN MEDICINE, 2024, 11
  • [4] The relationship between FENO and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma
    Hearn, Andrew P.
    Kavanagh, Joanne
    d'Ancona, Grainne
    Roxas, Cris
    Green, Linda
    Thomson, Louise
    Fernandes, Marianna
    Kent, Brian D.
    Dhariwal, Jaideep
    Nanzer, Alexanda M.
    Jackson, David J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 2093 - +
  • [5] Comparison of Clinical Efficacy Between Mepolizumab and Benralizumab in Severe Eosinophilic Asthma
    Okawa, K.
    Akamatsu, T.
    Sugiyama, S.
    Shiratori, K.
    Nakayasu, H.
    Masuda, T.
    Takahashi, S.
    Kitahara, Y.
    Kishimoto, Y.
    Sakurai, S.
    Saigusa, M.
    Yamamoto, A.
    Morita, S.
    Asada, K.
    Shirai, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [6] Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study
    Vantaggiato, Lorenza
    Perruzza, Marco
    Refini, Rosa Metella
    Bergantini, Laura
    D'Alessandro, Miriana
    Cameli, Paolo
    Perruzza, Davide
    Bini, Luca
    Bargagli, Elena
    Landi, Claudia
    LUNG, 2020, 198 (05) : 761 - 765
  • [7] Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study
    Lorenza Vantaggiato
    Marco Perruzza
    Rosa Metella Refini
    Laura Bergantini
    Miriana d’Alessandro
    Paolo Cameli
    Davide Perruzza
    Luca Bini
    Elena Bargagli
    Claudia Landi
    Lung, 2020, 198 : 761 - 765
  • [8] Mepolizumab and Benralizumab: new therapeutic perspectives for Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis
    Scarano, Paola
    Cisternino, Cecilia
    Lo Muzio, Giulia
    Calo, Olimpia
    Sanna, Arianna
    Steffanina, Alessia
    De Filippis, Francesca
    Leporini, Maria Teresa
    Palange, Paolo
    Graziani, Elda
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [9] EFFICACY OF BENRALIZUMAB AND MEPOLIZUMAB ON ASTHMA OUTCOMES IN PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
    Wechsler, M.
    Bourdin, A.
    Chanez, P.
    Jackson, D.
    Siddiqui, S.
    Specks, U.
    Baudy, P.
    Necander, S.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S49 - S50
  • [10] Benralizumab and mepolizumab treatment outcomes in two severe asthma clinics
    Langton, David
    Politis, John
    Collyer, Taya
    Khung, Su-Wei
    Bardin, Philip
    RESPIROLOGY, 2023, 28 (12) : 1117 - 1125
12345